tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Yon, 9 are a HOLD (39.13%), 2 are a SELL (8.7%), 12 are a BUY (52.17%).
Analyst Jonathan Yon, currently employed at UBS, carries an average stock price target met ratio of 66.67% that have a potential upside of 25.39% achieved within 280 days. Previously, Jonathan Yon worked at CREDIT SUISSE.
Jonathan Yon’s has documented 42 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLOV, Clover Health Investments Corp at 06-Aug-2025.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 8/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.21 (7.53%) receiving and performance score of 75.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Feb-2025
$5
$0.34 (7.30%)
$4.75
Buy Since 03-Feb-2022
$5.5
$0.84 (18.03%)
$4.2
Hold Since 19-Jan-2022
$2.5
$-2.16 (-46.35%)
$3
Hold Since 07-Oct-2024
$3
$-1.66 (-35.62%)
$4.5
Hold Since 10-Jan-2022
$1.8
$-0.13 (-6.74%)
$3.5
What Year was the first public recommendation made by Jonathan Yon?
